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Introduction 
Acutely decompensated heart failure(ADHF) leads to frequent hospitalisations and prolonged in-patient stay. A
specialist nurse-delivered HF unit with a multi-disciplinary approach could safely manage these patients in an
ambulatory setting without the need for hospitalisation.  
Purpose:  
Our ambulatory HF unit(AHFU) receives referrals from emergency department, primary care and community
teams. The unit provides intravenous(IV) bolus furosemide (if required) at 4mg/mt in an ambulatory setting. A
multi-disciplinary approach is used through regular input from day-case renal, pleural and ascites clinics, as well
as palliative care team.  We analysed the efﬁcacy of ambulatory management of ADHF and compared the
outcomes based on the ejection fraction(EF). 
Methods 
335 consecutive patients(479 patient visits) who received IV furosemide in the AHFU from December 2014 -to
December 2017 were included in this study. Mean follow-up was 10±6.7 months. Hospitalisations were compared
for an equal period pre and post-AHFU treatment. Statistical analysis was performed using One Way ANOVA or
Student's T test. 
Results 
 53% (179/335) patients had HF with reduced EF(HFREF), 35% (117/335) had HF with preserved EF (HFPEF) and
12% (39/335)  had HF with mildly reduced EF (HFmrEF). HFPEF patients were signiﬁcantly older (median age 80;
range 40-97;p=0.02) than HFmREF (76 years;range 28-93) or HFREF patients (76.5 years; range 18-96). There
were more males in the HFREF group (76% vs. 53% in HFPEF and 59% in HFmREF groups). HFREF patients also
had higher BNP levels (median 4555 ng/L range 267-35000; p<0.001 ) versus 2057 ng/L (range 215-35000) in
HFPEF and 1807 ng/L (range 236-11741) in  HFmREF. Baseline renal function (measured by eGFR) was similar in
the 3 groups(HFREF mean 49±20 ml/min; HFPEF 49±17 ml/min and HFmREF 46±17 ml/min; p=0.6).  
HFPEF patients required a higher dose of IV furosemide(median dose 200 mg, range 60-440mg; p=0.02) as well
as  a higher number of visits (mean 5.3±2.5; p<0.001) compared to HFREF patients (median dose 180mg;range
40-400 and mean no. of visits 4±2)  and HFmREF groups(median dose 200mg, range 80-480 and mean no. of
visits 4.3±2.1). HF hospitalisations reduced signiﬁcantly  in the HFREF group (mean 0.97±0.42 pre-AHFU service
to 0.45±0.1 post- AHFU treatment ;p<0.001), in HFPEF group (0.88±0.4 pre-AHFU to 0.4±0.1 post AHFU;p<0.001) 
and in the HFmREF group (0.84±0.35 pre-AHFU to 0.37±0.15 post-AHFU; p<0.001). Mortality during the follow-up
period was the highest  in the HFREF group (33%;p=0.03) when compared to HFMREF(12%) and HFPEF(24%).  
Conclusions 
A specialist HF nurse-led ambulatory unit can lead to a signiﬁcant reduction in hospitalisations for ADHF
irrespective of the EF. HFPEF patients are generally older, require higher diuretic doses and more prolonged
treatment compared to other sub-groups. Further research is required to ascertain if this could be due to a
higher degree of diuretic resistance.
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